Roxanol and Cerebral haemorrhage - a phase IV clinical study of FDA data

Summary:

Cerebral haemorrhage is reported as a side effect among people who take Roxanol (morphine sulfate), especially for people who are male, 60+ old, also take Peridex, and have Deep venous thrombosis.

The phase IV clinical study analyzes which people have Cerebral haemorrhage when taking Roxanol. It is created by eHealthMe based on reports of 804 people who have side effects when taking Roxanol from the FDA, and is updated regularly.

What is Roxanol?

Roxanol has active ingredients of morphine sulfate. eHealthMe is studying from 807 Roxanol users. Check the latest studies of Roxanol.

What is Cerebral haemorrhage?

Cerebral haemorrhage (bleeding within the brain) is found to be associated with 1,437 drugs and 1,502 conditions by eHealthMe. Check the latest studies of Cerebral haemorrhage.

On Jul, 17, 2026

804 people reported to have side effects when taking Roxanol.
Among them, 12 people (1.49%) have Cerebral haemorrhage.

Could Roxanol cause Cerebral haemorrhage?

Among these 12 people:

What is the gender of people who have Cerebral haemorrhage when taking Roxanol? *

female: 22.22 %
male: 77.78 %

What is the age of people who have Cerebral haemorrhage when taking Roxanol? *

What are other drugs people take besides Roxanol? *

What are other side effects people have besides Cerebral haemorrhage? *

Stress And Anxiety: 8 people, 66.67%
Anaemia (lack of blood): 8 people, 66.67%
Anhedonia (inability to experience pleasure from activities usually found enjoyable): 8 people, 66.67%
Metastases To Bone (cancer spreads to bone): 8 people, 66.67%
Upper Respiratory Tract Infection: 8 people, 66.67%
Diarrhea: 8 people, 66.67%
Back Pain: 8 people, 66.67%
Osteonecrosis Of Jaw (death of bone of jaw): 8 people, 66.67%
Cardiac Failure Congestive: 8 people, 66.67%
Neuropathy Peripheral (surface nerve damage): 8 people, 66.67%

What are the existing conditions these people have? *

Glioblastoma (most common and most aggressive malignant primary brain tumour in humans): 4 people, 33.33%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 4 people, 33.33%
Pain: 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 1 person, 8.33%
Insomnia (sleeplessness): 1 person, 8.33%
Hepatitis C: 1 person, 8.33%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 8.33%
Bone Density Decreased: 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Roxanol and have Cerebral haemorrhage?

- Check whether Cerebral haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Roxanol:

Roxanol (807 reports)

Browse all side effects of Roxanol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cerebral haemorrhage:

Cerebral haemorrhage (1,438 drugs)

Browse all the conditions that are associated with Cerebral haemorrhage:

Cerebral haemorrhage (1,502 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Roxanol) and Roxanol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.